Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ Naturearrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
Nature
Article
Data sources: UnpayWall
image/svg+xml Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Closed Access logo, derived from PLoS Open Access logo. This version with transparent background. http://commons.wikimedia.org/wiki/File:Closed_Access_logo_transparent.svg Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao
Nature
Article . 1989 . Peer-reviewed
License: Springer TDM
Data sources: Crossref
Nature
Article . 1989
Data sources: Europe PubMed Central
https://dx.doi.org/10.1038/342...
Article
Data sources: Microsoft Academic Graph
https://dx.doi.org/10.1038/342...
Article
Data sources: Microsoft Academic Graph
 View all 2 versions
Claim

Vaccines for the Third World

descriptionPublicationkeyboard_double_arrow_right Article 09 Nov 1989 English Publisher:Springer Science and Business Media LLCJournal:Nature, volume 342, pages 115-120 (issn: 0028-0836, eissn: 1476-4687, Copyright policy )
Authors: B R, Bloom;

doi: 10.1038/342115a0

pmid: 2812009

Vaccines for the Third World

Abstract

New vaccines, developed through genetic engineering, can make immunization an even more effective weapon for tackling disease in developing countries. So what is preventing progress?

Related Organizations
Keywords

Acquired Immunodeficiency Syndrome, Vaccines, Vaccines, Synthetic, Immunoglobulin Idiotypes, Bacterial Vaccines, Humans, Viral Vaccines, Vaccines, Attenuated, Developing Countries

  • BIP!
    Impact byBIP!
    selected citations
    These citations are derived from selected sources.
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    		 134
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    		 Top 10%
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    		 Top 1%
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    		 Top 10%
Powered by OpenAIRE graph
Found an issue? Give us feedback
selected citations
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
134
Top 10%
Top 1%
Top 10%
bronze